Home » Stocks » Quest Diagnostics

Quest Diagnostics Incorporated (DGX)

Stock Price: $121.75 USD 0.60 (0.50%)
Updated Aug 13, 2020 4:02 PM EDT - Market closed
After-hours: $121.50 -0.25 (-0.21%) Aug 13, 7:18 PM

Stock Price Chart

Key Info

Market Cap 16.35B
Revenue (ttm) 7.53B
Net Income (ttm) 752.00M
Shares Out 134.30M
EPS (ttm) 5.52
PE Ratio 22.06
Forward PE 18.02
Dividend $2.24
Dividend Yield 1.84%

Stock Quote

Trading Day Aug 13, 2020
Last Price $121.75
Previous Close $121.15
Change ($) 0.60
Change (%) 0.50%
Day's Open 120.74
Day's Range 119.80 - 121.77
Day's Volume 650,378
52-Week Range 73.02 - 131.81

More Stats

Market Cap 16.35B
Enterprise Value 20.50B
Earnings Date (est) Oct 27, 2020
Ex-Dividend Date Jul 7, 2020
Shares Outstanding 134.30M
Float 133.53M
EPS (basic) 5.59
EPS (diluted) 5.52
FCF / Share 6.77
Dividend $2.24
Dividend Yield 1.84%
Earnings Yield 4.53%
FCF Yield 5.55%
Payout Ratio n/a
Shares Short 2.76M
Short Ratio 2.00
Short % of Float 2.33%
Beta 1.38
PE Ratio 22.06
Forward PE 18.02
P/FCF Ratio 18.03
PS Ratio 2.17
PB Ratio 2.87
Revenue 7.53B
Operating Income 1.13B
Net Income 752.00M
Free Cash Flow 907.00M
Net Cash -4.15B
Net Cash / Share -30.89
Gross Margin 36.17%
Operating Margin 15.06%
Profit Margin 10.00%
FCF Margin 12.04%
ROA 5.61%
ROE 13.69%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (18)

Buy 10
Overweight 1
Hold 7
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$138.44*
(13.71% upside)
Low
120
Current: $121.75
High
155
Target: 138.44
*Average 12-month price target from 16 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue7,7267,5317,4027,2147,4937,4357,1467,3837,3927,260
Revenue Growth2.59%1.74%2.61%-3.72%0.78%4.04%-3.21%-0.12%1.82%-
Gross Profit2,6892,6052,6832,5982,8362,7982,8203,0183,0292,985
Operating Income1,2311,1011,1651,2771,3999831,0011,2019871,284
Net Income858736772645709556849556471721
Shares Outstanding135136136139143145145159158170
Earnings Per Share6.285.295.504.514.873.815.543.462.924.05
EPS Growth18.71%-3.82%21.95%-7.39%27.82%-31.23%60.12%18.49%-27.9%-
Dividend Per Share2.121.951.801.581.471.291.200.680.400.40
Dividend Growth8.72%8.33%13.92%7.48%13.95%7.5%76.47%70%0%-
Operating Cash Flow1,2431,2001,1751,1168219446521,1878951,118
Capital Expenditures-309-381-251-293-263-308-231-182-161-205
Free Cash Flow9348199248235586364211,005734913
Cash & Equivalents1,192135137359133192187296165449
Total Debt5,3283,8933,7843,7343,6513,7423,3323,3644,0252,990
Net Cash / Debt-4,136-3,758-3,647-3,375-3,518-3,550-3,145-3,068-3,860-2,541
Assets12,84311,00310,50310,1009,9629,8578,9489,2849,3138,528
Liabilities7,1565,7365,5485,4405,2495,5274,9755,0985,5984,474
Book Value5,6415,2164,9214,6284,6844,3013,9484,1633,6934,033
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Quest Diagnostics Incorporated
Country United States
Employees 47,000
CEO Stephen H. Rusckowski

Stock Information

Ticker Symbol DGX
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NYSE: DGX
IPO Date December 17, 1996

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated has a strategic collaboration with hc1; and strategic relationship with Clinical Genomics Pty Ltd. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.